Size-selective downstream processing of virus particles and non-enveloped virus-like particles

被引:7
|
作者
Hillebrandt, Nils [1 ]
Hubbuch, Juergen [1 ]
机构
[1] Karlsruhe Inst Technol KIT, Inst Engn Life Sci, Sec Biomol Separat Engn 4, Karlsruhe, Germany
关键词
virus particles; virus-like particles; vaccines; downstream processing; purification; size-selective; INFLUENZA-A; CHROMATOGRAPHIC PURIFICATION; PROTEIN; VACCINES; PRECIPITATION; STABILITY; DELIVERY; PLATFORM; VECTORS; CAPTURE;
D O I
10.3389/fbioe.2023.1192050
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Non-enveloped virus-like particles (VLPs) are versatile protein nanoparticles with great potential for biopharmaceutical applications. However, conventional protein downstream processing (DSP) and platform processes are often not easily applicable due to the large size of VLPs and virus particles (VPs) in general. The application of size-selective separation techniques offers to exploit the size difference between VPs and common host-cell impurities. Moreover, size-selective separation techniques offer the potential for wide applicability across different VPs. In this work, basic principles and applications of size-selective separation techniques are reviewed to highlight their potential in DSP of VPs. Finally, specific DSP steps for non-enveloped VLPs and their subunits are reviewed as well as the potential applications and benefits of size-selective separation techniques are shown.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Characterization of Chikungunya Virus-Like Particles
    Noranate, Nitchakarn
    Takeda, Naokazu
    Chetanachan, Prukswan
    Sittisaman, Pathompong
    A-nuegoonpipat, Atchareeya
    Anantapreecha, Surapee
    PLOS ONE, 2014, 9 (09):
  • [32] Virus-like particles in vaccine development
    Roldao, Antonio
    Mellado, Maria Candida M.
    Castilho, Leda R.
    Carrondo, Manuel J. T.
    Alves, Paula M.
    EXPERT REVIEW OF VACCINES, 2010, 9 (10) : 1149 - 1176
  • [33] Virus-Like Particles as Theranostic Platforms
    Sun, Xianxun
    Cui, Zongqiang
    ADVANCED THERAPEUTICS, 2020, 3 (05)
  • [34] Transcutaneous vaccination with virus-like particles
    Young, Sarah L.
    Wilson, Michelle
    Wilson, Sarah
    Beagley, Kenneth W.
    Ward, Vernon
    Baird, Margaret A.
    VACCINE, 2006, 24 (26) : 5406 - 5412
  • [35] Virus-Like Particles as Particulate Vaccines
    Buonaguro, Luigi
    Tornesello, Maria L.
    Buonaguro, Franco M.
    CURRENT HIV RESEARCH, 2010, 8 (04) : 299 - 309
  • [36] Production of virus-like particles for vaccines
    Fuenmayor, J.
    Godia, F.
    Cervera, L.
    NEW BIOTECHNOLOGY, 2017, 39 : 174 - 180
  • [37] Virus-like particles (VLP) in prophylaxis and immunotherapy of allergic diseases
    Klimek L.
    Kündig T.
    Kramer M.F.
    Guethoff S.
    Jensen-Jarolim E.
    Schmidt-Weber C.B.
    Palomares O.
    Mohsen M.O.
    Jakob T.
    Bachmann M.
    Allergo Journal International, 2018, 27 (8) : 245 - 255
  • [38] Expression and characterization of hepatitis E virus-like particles and non-virus-like particles from insect cells
    Qi, Ying
    Fan, Jinping
    Huang, Weijin
    Zhao, Chenyan
    Wang, Youchun
    Kong, Franklin T.
    Kong, Wei
    Jiang, Chunlai
    BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, 2016, 63 (03) : 362 - 370
  • [39] Dual display hemagglutinin 1 and 5 on the surface of enveloped virus-like particles in silkworm expression system
    Goffar, Muzajjad Gozal
    Deo, Vipin Kumar
    Kato, Tatsuya
    Park, Enoch Y.
    PROTEIN EXPRESSION AND PURIFICATION, 2022, 197
  • [40] Use of hollow fiber tangential flow filtration for the recovery and concentration of HIV virus-like particles produced in insect cells
    Negrete, Alejandro
    Pai, Amrita
    Shiloach, Joseph
    JOURNAL OF VIROLOGICAL METHODS, 2014, 195 : 240 - 246